We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Diabetes

Journal Scan / Research · February 24, 2021

Liraglutide Hospital Discharge Trial

Diabetes, Obesity & Metabolism


Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes, Obesity & Metabolism
Liraglutide Hospital Discharge Trial: A Randomized Controlled Trial Comparing the Safety and Efficacy of Liraglutide Versus Glargine Insulin for the Management of Patients With Type 2 Diabetes After Hospital Discharge
Diabetes Obes Metab 2021 Feb 16;[EPub Ahead of Print], FJ Pasquel, MA Urrutia, S Cardona, KW Zamudio Coronado, B Albury, MC Perez-Guzman, RJ Galindo, A Chaudhuri, G Iacobellis, J Palacios, JM Farias, P Gomez, I Anzola, P Vellanki, M Fayfman, GM Davis, AL Migdal, L Peng, GE Umpierrez

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading